Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christiane Querfeld

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Oncology (Williston Park, N.Y.)|January 2, 2010
Diagnostic and therapeutic challenges of primary cutaneous lymphomasChristiane Querfeld
The Journal of Investigative Dermatology|August 23, 2023
Unraveling the Mechanisms of PD-1 Regulation in Sézary Syndrome: Epigenetic Regulation as Potential Mechanism?Christiane Querfeld
Blood|June 30, 2022
Mechanisms of resistance to mogamulizumabChristiane Querfeld
Seminars in Diagnostic Pathology|January 2, 2010
Cutaneous CD30 lymphoproliferative disorders and similar conditions: a clinical and pathologic prospective on a complex issueJoan Guitart, Christiane Querfeld
Blood|November 8, 2019
The great masquerader mimicking plasma cell myelomaJoo Y Song, Christiane Querfeld
Hematology. American Society of Hematology. Education Program|November 25, 2006
Primary cutaneous T-cell lymphomasSteven T Rosen, Christiane Querfeld
Best Practice & Research. Clinical Haematology|September 15, 2018
Integrating novel systemic therapies for the treatment of mycosis fungoides and Sézary syndromeH Miles Prince, Christiane Querfeld
The New England Journal of Medicine|September 4, 2024
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell TherapyJames Godfrey, Christiane Querfeld, Joo Song
Current Opinion in Oncology|July 14, 2020
Targeting microRNA in hematologic malignanciesZhen Han, Steven T Rosen, Christiane Querfeld
Dermatologic Therapy|December 15, 2018
Relief of intractable pruritus with romidepsin in patients with cutaneous T-cell lymphoma: A series of four casesBrian Poligone, Belen Rubio-Gonzalez, Christiane Querfeld
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Oncology (Williston Park, N.Y.)|January 2, 2010
Diagnostic and therapeutic challenges of primary cutaneous lymphomasChristiane Querfeld
The Journal of Investigative Dermatology|August 23, 2023
Unraveling the Mechanisms of PD-1 Regulation in Sézary Syndrome: Epigenetic Regulation as Potential Mechanism?Christiane Querfeld
Blood|June 30, 2022
Mechanisms of resistance to mogamulizumabChristiane Querfeld
Seminars in Diagnostic Pathology|January 2, 2010
Cutaneous CD30 lymphoproliferative disorders and similar conditions: a clinical and pathologic prospective on a complex issueJoan Guitart, Christiane Querfeld
Blood|November 8, 2019
The great masquerader mimicking plasma cell myelomaJoo Y Song, Christiane Querfeld
Hematology. American Society of Hematology. Education Program|November 25, 2006
Primary cutaneous T-cell lymphomasSteven T Rosen, Christiane Querfeld
Best Practice & Research. Clinical Haematology|September 15, 2018
Integrating novel systemic therapies for the treatment of mycosis fungoides and Sézary syndromeH Miles Prince, Christiane Querfeld
The New England Journal of Medicine|September 4, 2024
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell TherapyJames Godfrey, Christiane Querfeld, Joo Song
Current Opinion in Oncology|July 14, 2020
Targeting microRNA in hematologic malignanciesZhen Han, Steven T Rosen, Christiane Querfeld
Dermatologic Therapy|December 15, 2018
Relief of intractable pruritus with romidepsin in patients with cutaneous T-cell lymphoma: A series of four casesBrian Poligone, Belen Rubio-Gonzalez, Christiane Querfeld
Pageof 14